JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M202058200 on March 23, 2002

J. Biol. Chem., Vol. 277, Issue 22, 19811-19816, May 31, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/22/19811    most recent
M202058200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilboa, R.
Right arrow Articles by Shoham, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilboa, R.
Right arrow Articles by Shoham, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structure of Formamidopyrimidine-DNA Glycosylase Covalently Complexed to DNA*

Rotem GilboaDagger §, Dmitry O. Zharkov§||**, Gali GolanDagger , Andrea S. Fernandes, Sue Ellen GerchmanDagger Dagger , Eileen MatzDagger Dagger , Jadwiga H. KyciaDagger Dagger , Arthur P. Grollman§§, and Gil ShohamDagger

From the Dagger  Department of Inorganic Chemistry and the Laboratory for Structural Chemistry and Biology, The Hebrew University of Jerusalem, Jerusalem 91904, Israel, the  Laboratory of Chemical Biology, Department of Pharmacological Sciences, State University of New York, Stony Brook, New York 11794, the || Novosibirsk Institute of Bioorganic Chemistry, Siberian Division of Russian Academy of Sciences, Novosibirsk 630090, Russia, and the Dagger Dagger  Department of Biology, Brookhaven National Laboratories, Upton, New York 11973

Received for publication, March 1, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

Formamidopyrimidine-DNA glycosylase (Fpg) is a DNA repair enzyme that excises oxidized purines from damaged DNA. The Schiff base intermediate formed during this reaction between Escherichia coli Fpg and DNA was trapped by reduction with sodium borohydride, and the structure of the resulting covalently cross-linked complex was determined at a 2.1-Å resolution. Fpg is a bilobal protein with a wide, positively charged DNA-binding groove. It possesses a conserved zinc finger and a helix-two turn-helix motif that participate in DNA binding. The absolutely conserved residues Lys-56, His-70, Asn-168, and Arg-258 form hydrogen bonds to the phosphodiester backbone of DNA, which is sharply kinked at the lesion site. Residues Met-73, Arg-109, and Phe-110 are inserted into the DNA helix, filling the void created by nucleotide eversion. A deep hydrophobic pocket in the active site is positioned to accommodate an everted base. Structural analysis of the Fpg-DNA complex reveals essential features of damage recognition and the catalytic mechanism of Fpg.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

Oxidative DNA damage is generated by a variety of environmental and endogenous agents, including ionizing radiation, certain chemicals, and products of aerobic metabolism (1). 8-oxoG1 is one of the most abundant forms of oxidative DNA damage (2). Due to its ability to form a Hoogstein-type base pair with adenine (3), 8-oxoG is miscoding (4) and mutagenic, resulting in Gright-arrowT transversions in bacterial and eukaryotic cells (5, 6). The potential harmful effects of this lesion are avoided by base excision repair. In Escherichia coli, formamidopyrimidine-DNA glycosylase (Fpg, EC 3.2.2.23) removes 8-oxoG, Me-FaPy, and several structurally related lesions from damaged DNA (7, 8). Fpg is a component of the "GO system" that includes MutY, a mismatch adenine-DNA glycosylase, and MutT, an 8-oxodGTPase (9, 10); E. coli strains deficient in any of these genes are strong mutators (11).

Fpg shares significant sequence homology with endonuclease VIII (Nei) of E. coli (12). Both proteins belong to a family unrelated by sequence or tertiary structure to a larger family of DNA glycosylases, for which the prototype is endonuclease III (Nth) (13, 14). The substrate specificity of Fpg differs significantly from Nei (7, 8, 15) but closely resembles that of the eukaryotic 8-oxoguanine-DNA glycosylase, Ogg1, a member of the Nth family (14, 16, 17). Fpg also possesses AP lyase activity, nicking the phosphodiester backbone of DNA at the site of the lesion. Base excision by Fpg is followed immediately by two beta -elimination steps, resulting in a single nucleotide gap flanked by phosphate termini (7). A Schiff base intermediate, involving Pro-1 of the enzyme and C1' of the damaged nucleotide, forms early in the reaction sequence and can be reductively trapped by treatment with NaBH4 forming a stable covalent complex (18, 19). The mechanism of cleavage is similar to that of Nei (15, 20), but not to that of Ogg1 where only one beta -elimination occurs, and the efficiency of the elimination step is very low compared with base excision (16, 17).

Comparing the structures of Fpg, Nei, and Ogg1 provides a unique opportunity to analyze features of damage recognition and catalysis common to DNA glycosylases/AP lyases. The presence of DNA enhances the analytic power of the model by revealing the precise nature of enzyme-DNA interactions. The structure of the human Ogg1 catalytic domain complexed to DNA has been solved (21, 22), as has the structure of E. coli Nei covalently cross-linked to DNA by NaBH4 (23). The structure of Fpg from Thermus thermophilus HB8 (Tth-Fpg) has recently been solved in the absence of DNA (24). Although mechanisms for lesion recognition and catalysis by Fpg have been suggested on the basis of this structure and on earlier biochemical studies of E. coli Fpg (8, 18, 24, 25), many questions remain unanswered regarding the mode of Fpg-DNA interactions and the catalytic reaction mechanism of this important DNA repair protein.

To investigate the mechanisms of Fpg-DNA interactions, we have utilized NaBH4 reduction of the Schiff base intermediate to produce a stable covalent cross-link between Fpg and duplex DNA. We crystallized and determined the three-dimensional structure of this complex at 2.1 Å, revealing for the first time the three dimensional precise mode of DNA binding by Fpg as well as several important features of the catalytic mechanism of this enzyme. We used this model to rationalize numerous biochemical observations and site-directed mutagenesis studies of Fpg. The present study provides insight into the structural basis of Fpg-DNA binding, furnishing information essential for a mechanistic understanding of DNA glycosylases.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

Oligonucleotides and Enzymes-- The 13-mers CCAGGA(8-oxoG)GAAGCC and GGCTTCATCCTGG were synthesized by established phosphoramidite chemistry (26) and annealed in a 1:1 ratio. The E. coli fpg gene was amplified from E. coli genomic DNA by PCR using Pfu DNA polymerase (Stratagene); NdeI and BamHI restriction sites were present on the primers. The amplified fragment was inserted into the NdeI-BamHI site of the pET13a plasmid (27) and used to transform B834(DE3) E. coli cells. To purify recombinant Fpg, cells from 1 liter of culture, induced with 50 µM isopropyl-1-thio-beta -D-galactopyranoside for 6 h at 37 °C, were lysed by treatment with 50 µg/ml lysozyme in Tris/EDTA buffer, pH 8.0, containing 1 mM phenylmethylsulfonyl fluoride. DNA was precipitated with 0.01% polyethyleneimine, 1 M NaCl, and the supernatant was treated with 45% saturated (NH4)2SO4. The pellet was dissolved in Buffer A (20 mM HEPES-NaOH, pH 7.5, 1 mM EDTA, 1 mM dithiothreitol, 200 mM NaCl), loaded on a Fractogel EMD SO<UP><SUB>3</SUB><SUP>−</SUP></UP> 650 (Merck) column equilibrated in the same buffer and eluted by a 200-600 mM NaCl gradient in Buffer A. Fractions containing Fpg were diluted, applied to a heparin-Sepharose CL-6B (Amersham Biosciences) column, and eluted with a 200-800% mM NaCl gradient in Buffer A. Fractions of at least 90% purity were used directly for cross-linking.

Preparation of the Fpg-DNA Covalent Complex-- The cross-linking reaction mixture (10 ml), including 100-200 nmol of duplex oligonucleotide, 1-2 mg of Fpg, 25 mM sodium phosphate, pH 6.8, 100 mM NaCl, 1 mM EDTA, and 50 mM NaBH4 was incubated for 30 min at 37 °C and then quenched by adding 400 mM glucose. The sample was loaded onto a Poros HQ 4.6/50 column (PerSeptive Biosystems) equilibrated in 50 mM Tris-HCl, 5 mM MgCl2, 200 mM NaCl, eluted at 460 mM NaCl, concentrated to 1.8-2.0 mg/ml in a Centricon-3 device (Millipore), and used for crystallization experiments.

Crystallization and Data Collection-- Crystals were obtained by mixing 2-µl volumes of Fpg-DNA complex and reservoir solution (30% (w/v) polyethylene glycol 8000, 0.2 M (NH4)2SO4, 0.1 M sodium cacodylate pH 6.5), and equilibrating the drop with 1 ml of reservoir solution at 15 °C for several days. X-ray diffraction data (Table I) were collected on crystals soaked for ~3 min in a solution composed of 80% reservoir solution, 20% glycerol and flash-cooled to 100 K under a cold nitrogen gas stream. Data were obtained with a Quantum-4 CCD area detector (ADSC) at the National Synchroton Light Source X26C beamline, Brookhaven National Laboratory, and processed with DENZO and SCALEPACK (28).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Crystallographic data collection and refinement parameters

Structure Determination-- Matthews coefficient calculations suggest four Fpg-DNA monomers in an asymmetric unit. The Fpg-DNA structure was determined by molecular replacement (MR), using REPLACE (29, 30) and CNS (31). Polar angle self-rotation function calculations resulted in two major peaks, indicating an asymmetric unit of 222 non-crystallographic symmetry. Rotation and translation functions calculations employed all data in the 10.0-4.0-Å resolution range. Structures of Tth-Fpg (24) (1EE8) and a recently determined Nei-DNA complex (Ref. 23, 1K3W) were combined to form a search model for MR. Calculations imposing non-crystallographic symmetry, implemented in the "locked" cross rotation function in REPLACE, resulted in clear separation between the top and the second peaks, with no overlap between monomers in the unit cell. A translation function search was performed with CNS, using the constructed Fpg-DNA tetramer as a search model and including Patterson correlation refinement (32) and rigid body refinement for each of the monomers. This search gave a clear MR solution that was used for later stages of refinement. Solvent flipping (33) and 4-fold averaging, calculated to 2.1 Å resolution, increased the overall figure of merit from 0.42 to 0.89.

Electron density maps were calculated from the refined MR phases. An initial model was constructed using the program "O" (34), allowing clear determination of most of the structure, including components (e.g. zinc ion and most of the DNA bases) missing from the search model. The model was subjected to simulated annealing and iterative cycles of positional and temperature factor refinement, followed by manual fitting and rebuilding. An overall anisotropic temperature factor and bulk solvent correction factor were applied throughout the calculation. Progress of the refinement was monitored via Rfree (35). Strict non-crystallographic symmetry constraints were applied in the initial rounds of refinement. Subsequently, tight non-crystallographic symmetry restraints (force constant of 300 kcal/mol) were applied to allow proper refinement of regions significantly different in structure from that of the search model. All of the DNA and most of the protein residues were identified, except for the loop including residues 217-224 and the side chains of several amino acids remote from the protein-DNA interface. Water molecules were assigned to peaks in the [Fo - Fc] electron density maps larger than 3sigma and within potential hydrogen-bonding distance. The figures were prepared using MidasPlus (36), MOLSCRIPT (37), BOBSCRIPT (38), Raster3D (39), and GRASP (40). 3DNA (41) was used to calculate various DNA structural parameters.

Molecular Modeling and Conservation Analysis-- A model of Fpg complexed with the DNA duplex containing an everted 8-oxodG residue was built based on the current structure and the structure of 8-oxoG-containing DNA from the Ogg1-DNA complex (1EBM, Ref. 21). The missing residues 217-224 were modeled based on the corresponding loop of Tth-Fpg (1EE8, Ref. 24). The model was subjected to a series of energy minimization steps using the Discover module of Insight II (Accelrys) until the root mean-squared gradient was smaller than 0.001 kcal/(mol·Å). All energy optimizations were performed using the AMBER force field (42) with a distance-dependent dielectric constant of 4r, using the steepest descent and conjugate gradient methods. The phosphorus atoms of the DNA and the Calpha atoms of the protein, except for the newly built loop, were restrained with harmonic forces. To find a conformation with lower energy for the missing loop and the everted 8-oxodG, we also performed simulated annealing molecular dynamic runs from 1000 to 298 K. The conservation of residues within the Nei and Fpg subfamilies of the Fpg family was analyzed using the AMAS algorithm (43) and the cluster of orthologous groups data base (44), as described elsewhere (23).

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

Overall Structure-- The overall structure of Fpg comprises two domains connected by a hinge polypeptide (Fig. 1, a and b) and resembles that of Tth-Fpg (24) and E. coli Nei (23). The N-terminal domain contains eight beta -strands, forming a beta -sandwich with two alpha -helices parallel to its edges. The C-terminal domain includes four alpha -helices, two of which, alpha D and alpha E, form the helix-two turn-helix (H2TH) motif, and two beta -strands that form a beta -hairpin zinc finger.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 1.   Overall structure of Fpg-DNA. a, view perpendicular to the long axis of Fpg, demonstrating the DNA binding cleft. The N-terminal domain is shown in green, the interdomain hinge in red, and the C-terminal domain in blue, except for the H2TH (purple) and zinc finger (cyan) motifs. The zinc atom is represented by a gray ball and the covalently linked Pro-1 is highlighted is cyan. The DNA backbone is colored orange and bases in yellow. b, view approximately orthogonal to a, highlighting the protein-DNA contact area and the DNA kink.

The excised base, 8-oxoG, is not retained in the crystal. The ring-opened deoxyribitol moiety (dRbl), formed after base excision and NaBH4 reduction, is everted from the helix with C1' bound covalently to Nalpha of Pro-1 (Fig. 2), as suggested by biochemical experiments identifying Pro-1 as the residue involved in Schiff base formation (18, 19). DNA is severely kinked at the lesion point (roll angle, 66°), and the minor groove is significantly widened. Except at the lesion site, the DNA is essentially B-form. As commonly observed in DNA-binding proteins, the DNA-binding groove is positively charged (Fig. 3).


View larger version (77K):
[in this window]
[in a new window]
 
Fig. 2.   Experimental electron density map ([2Fo - Fc] coefficients at 3.0sigma contour level) around the dRbl-Pro-1 region, demonstrating clarity of the structure at 2.1 Å resolution. Note the Pro-1 Nalpha -dRbl covalent bond and close proximity of Oepsilon 2 of Glu-2 to O4' of dRbl and of Lys-56 to P-1 and P-2.


View larger version (85K):
[in this window]
[in a new window]
 
Fig. 3.   The solvent-accessible surface of Fpg, colored according to electrostatic potential and demonstrating the positive DNA binding cleft. The bound 13-mer DNA duplex is superimposed on the positively charged surface as a stick model (yellow). The negatively charged binding pocket is clearly seen in the center of the groove, containing the modeled 8-oxoG (inset).

Fpg-DNA Interactions-- Binding to DNA involves extensive interactions between Fpg and DNA (Fig. 4). A hydrogen bond network involving all loops that face DNA comprises 2512 Å2 of contact surface area. This relatively large buried surface area is consistent with the heat capacity change reported for Fpg binding to a lesion-containing duplex.2 A similar value for binding-induced burial of previously exposed solvent accessible surface area (2268 Å2) has been reported for Ogg1 (21); significantly higher than for human alkylpurine-DNA glycosylase (1034 Å2) (45) and uracil-DNA glycosylase (700 Å2) (46).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 4.   Schematic representation of Fpg-DNA interactions. The central nucleotides of the modified and complementary strands are 8-oxoG0 and C(0), respectively. Nucleotides are numbered as shown with those in the complementary strand in parentheses.

Fpg mainly contacts the damaged strand 3' to dRbl (P0, P-1, P-2) via side chains and backbone hydrogen atoms of the highly conserved Lys-56, His-70, Asn-168, Tyr-236, and Arg-258 residues. Fpg binds DNA in the minor groove; the damaged base is extruded from the helix through the major groove (Fig. 3). The complementary strand is held in position largely through Watson-Crick bonds; interactions with the enzyme are few, and except for His-89, the amino acids involved are not conserved.

Asn-168, Arg-258, and Lys-56 contact P0, P-1, and P-2, stabilizing the complex (Fig. 5a). Asn-168 is part of the H2TH motif and forms bonds through backbone and side chain amides to P-1 and P0, respectively. The zinc finger forms four hydrogen bonds with the phosphodiester backbone, three of which involve Arg-258 (two to P0, one to P-1) and one via Gln-257, to P(3). Lys-56, located on the beta 2-beta 3 loop, forms hydrogen bonds with P-1 and P-2.


View larger version (65K):
[in this window]
[in a new window]
 
Fig. 5.   Stereoview of specific interactions between Fpg and DNA. a, interactions of protein residues with DNA phosphates around the lesion. b, residues filling the void in DNA, demonstrating the intrusion of Met-73 and the specific interactions of Arg-108 with bases on both DNA strands. Protein side chain carbons are shown in light green and the relevant secondary structure elements in gray. DNA base carbons are shown in dark green.

Interactions at the Lesion Site-- Extrusion of the damaged base, which facilitates its binding in the enzyme active site, is a common structural feature of DNA glycosylases (21, 45, 47, 48). Eversion of deoxyribose is achieved by rotation around the P-O5' and O3'-P bonds. The geometry of Fpg-induced DNA kinking differs from that observed for uracil-DNA glycosylase (46, 47) and Ogg1 (21), which "pinch" the DNA backbone at the extrusion site, decreasing the normal distance (~12 Å in B-DNA) between P-1 and P1 by 30-50%. Similar to E. coli and human alkylpurine-DNA glycosylases complexed with DNA (45, 48), Fpg does not compress the phosphodiester backbone (P-1-P1 is 11.4 Å). Thus, base eversion is not absolutely dependent on strain induced by massive backbone compression (46, 47). Nucleotide eversion effected by Fpg may be achieved by "holding" the flanking phosphates with Lys-56, Asn-168, and Arg-258, coupled with intercalation of hydrophobic residues into duplex DNA (49) (Fig. 5, a and b). The energy required for extruding a single base from kinked double helical DNA has been estimated at ~3 kcal/mol (50), a barrier readily attained through noncovalent enzyme-DNA interactions.

Eversion of dRb1, coupled with loss of a base, creates a substantial gap between opposite strands, reflected in the 14.7 Å distance between C1' of dRb1 and C(0), as compared with 10.5 Å in B-DNA. The gap is filled by the hydrophobic residues Met-73, Arg-108, and Phe-110 (Fig. 5b). Met-73, part of the beta 4-beta 5 loop, enters the helix through the minor groove, occupying the position vacated by the extruded base. Arg-108 and Phe-110 are located on the beta 7-beta 8 loop. Phe-110, wedged between C(1) and C(0), engages in face-to-face pi  interactions (51) with the C(1) pyrimidine ring. Unstacking of these bases may contribute significantly to DNA kinking. C(0) remains intrahelical, stabilized by hydrogen bonds from O2 and N3 to Arg-108, contributing to Fpg specificity through opposite base recognition (Fig. 5b).

The position of dRb1 is fixed by the Nalpha -C1' covalent bond and the absolutely conserved Glu-2, which forms a hydrogen bond with O4'. Glu-2 is stabilized by hydrogen bonds to backbone amides of Ile-169 and Gly-167 located in the H2TH alpha E helix. Because the E2Q mutation inactivates the glycosylase activity of Fpg, but does not affect its AP lyase activity (52), Glu-2 probably is involved in protonation of O4' during base excision (53) (Fig. 6a).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 6.   Scheme of principal steps in the sequence of reactions catalyzed by Fpg, showing catalytically important amino acid residues. Nucleophilic attack at C1' and protonation at O4' (a) lead to base displacement and deoxyribose ring opening. A Schiff base involving Pro-1 is formed with O4' stabilized by hydrogen bonding to Glu-2. b, following abstraction of the 2' proton of deoxyribose by a general base, Lys-56 protonates the 3'-phosphate leading to beta -elimination (c). Deprotonation of C4', now vinilogous to C1', is followed by protonation of the 5'-phosphate by Arg-258 and the second beta -elimination event (c).

8-OxoG-binding Site-- A deep binding pocket for the everted base formed by Pro-1, Glu-2, Glu-5, Ile-169, Tyr-170, Thr-214, Thr-215, and Leu-216 is clearly visible (Fig. 3); however, the excised 8-oxoG base could not be located in our electron density maps. We searched for the site of 8-oxoG binding using two independent approaches. Computer simulation involving energy minimization and molecular dynamics, with 8-oxoG and the 217-224 loop modeled in the structure, suggested this site for the 8-oxoG-binding pocket. When the 217-224 loop is present, the side chain of Lys-217 closes the pocket, extending along the Hoogstein face of 8-oxoG and isolating it from the solvent. This conformation places Nzeta of Lys-217 in the proximity of 8-oxoG N7 and O8 atoms [Nzeta (Lys-217)-N7(8-oxoG), 3.56 Å; Nzeta (Lys-217)-O8(8-oxoG), 3.39 Å], making Lys-217 an ideal moiety for the recognition of the 8-oxoG lesion.

In addition, we analyzed conservation of amino acid residues in the Fpg family, which can be divided into Fpg and Nei subfamilies (54). At some positions, residues are highly conserved within the Fpg subfamily but not within the Nei subfamily. Alternatively, they may be conserved within the Nei subfamily but differ significantly in their physicochemical properties from residues at the respective positions of Fpg subfamily members. Such "dissimilar" residues may be important for functions specific to the Fpg subfamily, the most obvious of which is substrate specificity. When dissimilar residues are mapped on the surface of Fpg, several of them (Glu-5, Ile-169, Tyr-170) fall into the pocket identified by modeling, suggesting the importance of this region for 8-oxoG-specific recognition.

Mechanistic Implications-- The present structure may be used to rationalize the wealth of biochemical data accumulated for Fpg (53, 55). Pro-1 and Glu-2 are critical for base release in the Fpg-catalyzed reaction. During the consecutive beta -elimination steps that follow (56), Fpg must protonate the leaving phosphates. Lys-56 and Arg-258 are well positioned to protonate P-1 and P0, respectively (Fig. 6, b and c). Following elimination of P-1, its contact with Arg-258 may be relaxed, allowing this residue to move closer to P0 for more efficient protonation. Surprisingly, the conformation of dRbl in the catalytic intermediate is inconsistent with the syn stereochemistry of pro-S-2' hydrogen abstraction proposed for other AP lyases (57, 58), suggesting an anti stereochemical course.

Peptide mapping, site-directed mutagenesis, and mass spectrometric experiments established Pro-1 as the site of Schiff base formation (18, 19). The Fpg-DNA structure confirms that Pro-1 Nalpha is covalently bound to C1'. Fluorescence experiments suggest that the structure of P1E Fpg is more rigid than that of wild type Fpg and P1G and K56G mutants (59). Pro-1 lies at the head of a long helix alpha A, which in addition to a standard dipole moment has acidic N-terminal and basic C-terminal halves. P1E mutation further increases dipole moment, strengthening electrostatic interactions with Lys-56 and Arg-258 and tightening the protein globule.

Mutations of conserved glutamates Glu-2, Glu-5, Glu-131, and Glu-173 to glutamines decrease the glycosylase but not the AP lyase activity of Fpg (52). Glu-2 stabilizes and protonates O4' of dRbl (Fig. 6a) and may activate Pro-1 for nucleophilic attack ((Glu-2)Oepsilon 2-Nalpha (Pro-1), 5.71 Å). Glu-5, which moderates Fpg activity, may help orient Glu-2 for catalysis via interaction with its backbone amide. In addition, Glu-2 and Glu-5 participate in forming the 8-oxoG-binding pocket. Glu-131 forms hydrogen bonds to Arg-53, Arg-54, and Ala-55, stabilizing the beta 2-beta 3 loop and bringing together the N- and C-terminal domains; loss of these interactions would affect positioning of Lys-56. Glu-173 forms hydrogen bonds with the backbone amides of Gln-234, Val-235, and Tyr-236, stabilizing the turn formed by these residues. This turn, together with the edge-to-face interaction (51) with Phe-261, helps orient Tyr-236, which donates a hydrogen bond to P0. Hydrogen bonding by these Glu residues is modified upon mutation to Gln. In contrast, conversion of the conserved Asp-106 and Asp-159 residues to Asn retains hydrogen bonding capability; these mutations do not affect Fpg activity (52).

Lys-56 and Lys-154 have been implicated in substrate specificity. Mutations K56G, K56R, and K154A reduce the efficiency of Fpg acting on substrates containing 8-oxoG but not on DNA containing Me-FaPy or AP sites (25, 60). These conserved residues participate in a hydrogen-bonding network near dRbl, with Lys-56 contacting P-1 and P-2 and Lys-154 forming a strong hydrogen bond to Odelta 1 of Asn-168. Nucleotide eversion moves the beta  position of C1' away from these residues, making it unlikely that they will participate in recognition of the damaged base. However, Me-FaPy is less stable than 8-oxoG to acid-catalyzed depurination and protonation of the base; alternatively, protonation of O4' may be sufficient to break the glycosidic bond of this lesion. The resulting AP site would be less sensitive to the loss of Lys-56 or Lys-154 due to spontaneous opening of the deoxyribose ring, which relaxes the requirement for strict positioning of C1' for nucleophilic attack (23).

DNA binding by Fpg is abolished by mutation of any of the four cysteines in the zinc finger (61, 62). This motif exists as a separate subdomain, and its disruption would not affect overall folding, consistent with circular dichroism data (61), but would create conformational changes that affect positioning of the conserved Arg-258. In the zinc finger mutants, AP lyase activity is affected less than base excision activity (62), consistent with our observation that mutation of the homologous Arg-252 in Nei inactivates glycosylase, but not AP lyase activity (23). Cysteines 146 and 194 are remote from the active site and when mutated have little effect on enzymatic function (62).

In conclusion, the crystal structure of Fpg cross-linked to duplex DNA reveals the mode of substrate binding for this important family of DNA glycosylases and identifies highly conserved active site residues involved in the catalytic action of this enzyme. The structural data presented here clarify many of the biochemical properties reported for Fpg. They provide insights into the nature of protein-nucleic acid interactions and facilitate our understanding of mechanisms of base excision repair.

    ACKNOWLEDGEMENTS

We thank Cecilia Torres for preparing the oligonucleotides used in this study, Erich Bremer for help in preparing images, and Dr. Dieter Schneider for expert assistance in collecting data on the X26C beamline at NSLS.

    FOOTNOTES

* This investigation was supported by Research Grants CA-17395 and CA-47995 (to A. P. G.) from the National Institutes of Health. Work at Brookhaven National Laboratories was supported by the office of Biological and Environmental Research of the United States Department of Energy.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The atomic coordinates and the structure factors (code 1K82) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

§ These individuals contributed equally to this work.

** A recipient of Grant 02-04-49605 from the Russian Foundation for Basic Research.

§§ To whom correspondence should be addressed. Tel.: 631-444-3080; Fax: 631-444-7641; E-mail: apg@pharm.sunysb.edu.

Published, JBC Papers in Press, March 23, 2002, DOI 10.1074/jbc.M202058200

2 C. A. Minetti, D. P. Remeter, E. G. Plum, and K. J. Breslauer, unpublished observations.

    ABBREVIATIONS

The abbreviations used are: 8-oxoG, 8-oxo-7,8-dihydroguanine; 8-oxodG, 8-oxo-7,8-dihydro-2'-deoxyguanosine; dRbl, deoxyribitol; Tth-Fpg, Thermus thermophilus formamidopyrimidine-DNA glycosylase; H2TH, helix-two turn-helix motif; Me-FaPy, 2,6-diamino-4-hydroxy-5N-methylformamidopyrimidine; MR, molecular replacement, Nei, endonuclease VIII; Nth, endonuclease III; Ogg1, 8-oxoguanine-DNA glycosylase; AP, apurinic/apyrimidinic.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

1. von Sonntag, C. (1987) The Chemical Basis of Radiation Biology , Taylor & Francis, London
2. Burrows, C. J., and Muller, J. G. (1998) Chem. Rev. 98, 1109-1151[CrossRef][Medline] [Order article via Infotrieve]
3. Kouchakdjian, M., Bodepudi, V., Shibutani, S., Eisenberg, M., Johnson, F., Grollman, A. P., and Patel, D. J. (1991) Biochemistry 30, 1403-1412[CrossRef][Medline] [Order article via Infotrieve]
4. Shibutani, S., Takeshita, M., and Grollman, A. P. (1991) Nature 349, 431-434[CrossRef][Medline] [Order article via Infotrieve]
5. Moriya, M., Ou, C., Bodepudi, V., Johnson, F., Takeshita, M., and Grollman, A. P. (1991) Mutat. Res. 254, 281-288[Medline] [Order article via Infotrieve]
6. Moriya, M. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 1122-1126[Abstract/Free Full Text]
7. Tchou, J., Kasai, H., Shibutani, S., Chung, M.-H., Laval, J., Grollman, A. P., and Nishimura, S. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 4690-4694[Abstract/Free Full Text]
8. Tchou, J., Bodepudi, V., Shibutani, S., Antoshechkin, I., Miller, J., Grollman, A. P., and Johnson, F. (1994) J. Biol. Chem. 269, 15318-15324[Abstract/Free Full Text]
9. Michaels, M. L., Tchou, J., Grollman, A. P., and Miller, J. H. (1992) Biochemistry 31, 10964-10968[CrossRef][Medline] [Order article via Infotrieve]
10. Michaels, M. L., and Miller, J. H. (1992) J. Bacteriol. 174, 6321-6325[Free Full Text]
11. Tajiri, T., Maki, H., and Sekiguchi, M. (1995) Mutat. Res. 336, 257-267[Medline] [Order article via Infotrieve]
12. Jiang, D., Hatahet, Z., Blaisdell, J. O., Melamede, R. J., and Wallace, S. S. (1997) J. Bacteriol. 179, 3773-3782[Abstract/Free Full Text]
13. Thayer, M. M., Ahern, H., Xing, D., Cunningham, R. P., and Tainer, J. A. (1995) EMBO J. 14, 4108-4120[Medline] [Order article via Infotrieve]
14. Nash, H. M., Bruner, S. D., Shärer, O. D., Kawate, T., Addona, T. A., Spooner, E., Lane, W. S., and Verdine, G. L. (1996) Curr. Biol. 6, 968-980[CrossRef][Medline] [Order article via Infotrieve]
15. Jiang, D., Hatahet, Z., Melamede, R. J., Kow, Y. W., and Wallace, S. S. (1997) J. Biol. Chem. 272, 32230-32239[Abstract/Free Full Text]
16. Rosenquist, T. A., Zharkov, D. O., and Grollman, A. P. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 7429-7434[Abstract/Free Full Text]
17. Zharkov, D. O., Rosenquist, T. A., Gerchman, S. E., and Grollman, A. P. (2000) J. Biol. Chem. 275, 28607-28617[Abstract/Free Full Text]
18. Tchou, J., and Grollman, A. P. (1995) J. Biol. Chem. 270, 11671-11677[Abstract/Free Full Text]
19. Zharkov, D. O., Rieger, R. A., Iden, C. R., and Grollman, A. P. (1997) J. Biol. Chem. 272, 5335-5341[Abstract/Free Full Text]
20. Rieger, R. A., McTigue, M. M., Kycia, J. H., Gerchman, S. E., Grollman, A. P., and Iden, C. R. (2000) J. Am. Soc. Mass Spectrom. 11, 505-515[CrossRef][Medline] [Order article via Infotrieve]
21. Bruner, S. D., Norman, D. P. G., and Verdine, G. L. (2000) Nature 403, 859-866[CrossRef][Medline] [Order article via Infotrieve]
22. Norman, D. P. G., Bruner, S. D., and Verdine, G. L. (2001) J. Am. Chem. Soc. 123, 359-360[CrossRef][Medline] [Order article via Infotrieve]
23. Zharkov, D. O., Golan, G., Gilboa, R., Fernandes, A. S., Gerchman, S. E., Kycia, J. H., Rieger, R. A., Grollman, A. P., and Shoham, G. (2002) EMBO J. 23, 789-800[CrossRef]
24. Sugahara, M., Mikawa, T., Kumasaka, T., Yamamoto, M., Kato, R., Fukuyama, K., Inoue, Y., and Kuramitsu, S. (2000) EMBO J. 19, 3857-3869[CrossRef][Medline] [Order article via Infotrieve]
25. Rabow, L. E., and Kow, Y. W. (1997) Biochemistry 36, 5084-5096[CrossRef][Medline] [Order article via Infotrieve]
26. Bodepudi, V., Shibutani, S., and Johnson, F. (1992) Chem. Res. Toxicol. 5, 608-617[CrossRef][Medline] [Order article via Infotrieve]
27. Gerchman, S. E., Graziano, V., and Ramakrishnan, V. (1994) Protein Expr. Purif. 5, 242-251[CrossRef][Medline] [Order article via Infotrieve]
28. Otwinowski, Z., and Minor, W. (1997) Methods Enzymol. 276, 307-326
29. Tong, L., and Rossmann, M. G. (1990) Acta Crystallogr. A46, 783-792
30. Tong, L. (1993) J. Appl. Crystallogr. 26, 748-751
31. Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Crystallogr. D54, 905-921
32. Brünger, A. T. (1990) Acta Crystallogr. A46, 46-57
33. Abrahams, J. P., and Leslie, A. G. W. (1996) Acta Crystallogr. D52, 30-42
34. Jones, T. A., Zou, J.-Y., Cowan, S. W., and Kjeldgaard, M. (1991) Acta Crystallogr. A47, 110-119
35. Brünger, A. T. (1992) Nature 355, 472-475[CrossRef][Medline] [Order article via Infotrieve]
36. Ferrin, T. E., Huang, C. C., Jarvis, L. E., and Langridge, R. (1988) J. Mol. Graphics 6, 13[Medline] [Order article via Infotrieve]- 27, 36-37
37. Kraulis, P. J. (1991) J. Appl. Crystallogr. 24, 946-950[CrossRef]
38. Esnouf, R. M. (1997) J. Mol. Graphics 15, 132-134[CrossRef]
39. Merrit, E. A., and Bacon, D. J. (1997) Methods Enzymol. 277, 505-524[Medline] [Order article via Infotrieve]
40. Nicholls, A., Sharp, K. A., and Honig, B. (1991) Proteins 11, 281-296[CrossRef][Medline] [Order article via Infotrieve]
41. Lu, X.-J., Shakked, Z., and Olson, W. K. (2000) J. Mol. Biol. 300, 819-840[CrossRef][Medline] [Order article via Infotrieve]
42. Weiner, S. J., Kollman, P. A., Case, D. A., Singh, U. C., Ghio, C., Alagona, G., Profeta, S., Jr., and Weiner, P. (1984) J. Am. Chem. Soc. 106, 765-784[CrossRef]
43. Livingstone, C. D., and Barton, G. J. (1993) Comput. Appl. Biosci. 9, 745-756[Abstract/Free Full Text]
44. Tatusov, R. L., Natale, D. A., Garkavtsev, I. V., Tatusova, T. A., Shankavaram, U. T., Rao, B. S., Kiryutin, B., Galperin, M. Y., Fedorova, N. D., and Koonin, E. V. (2001) Nucleic Acids Res. 29, 22-28[Abstract/Free Full Text]
45. Lau, A. Y., Schärer, O. D., Samson, L., Verdine, G. L., and Ellenberger, T. (1998) Cell 95, 249-258[CrossRef][Medline] [Order article via Infotrieve]
46. Parikh, S. S., Mol, C. D., Slupphaug, G., Bharati, S., Krokan, H. E., and Tainer, J. A. (1998) EMBO J. 17, 5214-5226[CrossRef][Medline] [Order article via Infotrieve]
47. Slupphaug, G., Mol, C. D., Kavli, B., Arvai, A. S., Krokan, H. E., and Tainer, J. A. (1996) Nature 384, 87-92[CrossRef][Medline] [Order article via Infotrieve]
48. Hollis, T., Ichikawa, Y., and Ellenberger, T. (2000) EMBO J. 19, 758-766[CrossRef][Medline] [Order article via Infotrieve]
49. Werner, R. M., Jiang, Y. L., Gordley, R. G., Jagadeesh, G. J., Ladner, J. E., Xiao, G., Tordova, M., Gilliland, G. L., and Stivers, J. T. (2000) Biochemistry 39, 12585-12594[CrossRef][Medline] [Order article via Infotrieve]
50. van Aalten, D. M. F., Erlanson, D. A., Verdine, G. L., and Joshua-Tor, L. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 11809-11814[Abstract/Free Full Text]
51. Burley, S. K., and Petsko, G. A. (1985) Science 229, 23-28[Abstract/Free Full Text]
52. Lavrukhin, O. V., and Lloyd, R. S. (2000) Biochemistry 39, 15266-15271[CrossRef][Medline] [Order article via Infotrieve]
53. McCullough, A. K., Dodson, M. L., and Lloyd, R. S. (1999) Annu. Rev. Biochem. 68, 255-285[CrossRef][Medline] [Order article via Infotrieve]
54. Zharkov, D. O., and Grollman, A. P. (2002) Free Radic. Biol. Med. 32, 1254-1263
55. David, S. S., and Williams, S. D. (1998) Chem. Rev. 98, 1221-1261[CrossRef][Medline] [Order article via Infotrieve]
56. Bhagwat, M., and Gerlt, J. A. (1996) Biochemistry 35, 659-665[CrossRef][Medline] [Order article via Infotrieve]
57. Mazumder, A., Gerlt, J. A., Rabow, L., Absalon, M. J., Stubbe, J., and Bolton, P. H. (1989) J. Am. Chem. Soc. 111, 8029-8030[CrossRef]
58. Mazumder, A., Gerlt, J. A., Absalon, M. J., Stubbe, J., Cunningham, R. P., Withka, J., and Bolton, P. H. (1991) Biochemistry 30, 1119-1126[CrossRef][Medline] [Order article via Infotrieve]
59. Kuznetsov, S. V., Sidorkina, O. M., Jurado, J., Bazin, M., Tauc, P., Brochon, J.-C., Laval, J., and Santus, R. (1998) Eur. J. Biochem. 253, 413-420[Medline] [Order article via Infotrieve]
60. Sidorkina, O. M., and Laval, J. (1998) Nucleic Acids Res. 26, 5351-5357[Abstract/Free Full Text]
61. Tchou, J., Michaels, M. L., Miller, J. H., and Grollman, A. P. (1993) J. Biol. Chem. 268, 26738-26744[Abstract/Free Full Text]
62. O'Connor, T. R., Graves, R. J., de Murcia, G., Castaing, B., and Laval, J. (1993) J. Biol. Chem. 268, 9063-9070[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. A. S. A. Minetti, D. P. Remeta, and K. J. Breslauer
A continuous hyperchromicity assay to characterize the kinetics and thermodynamics of DNA lesion recognition and base excision
PNAS, January 8, 2008; 105(1): 70 - 75.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Couve-Privat, G. Mace, F. Rosselli, and M. K. Saparbaev
Psoralen-induced DNA adducts are substrates for the base excision repair pathway in human cells
Nucleic Acids Res., September 27, 2007; 35(17): 5672 - 5682.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Baker, G. Wuenschell, L. Xia, J. Termini, S. E. Bates, A. D. Riggs, and T. R. O'Connor
Nucleotide Excision Repair Eliminates Unique DNA-Protein Cross-links from Mammalian Cells
J. Biol. Chem., August 3, 2007; 282(31): 22592 - 22604.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. O. Blaisdell and S. S. Wallace
Rapid determination of the active fraction of DNA repair glycosylases: a novel fluorescence assay for trapped intermediates
Nucleic Acids Res., March 12, 2007; 35(5): 1601 - 1611.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Rogacheva, A. Ishchenko, M. Saparbaev, S. Kuznetsova, and V. Ogryzko
High Resolution Characterization of Formamidopyrimidine-DNA Glycosylase Interaction with Its Substrate by Chemical Cross-linking and Mass Spectrometry Using Substrate Analogs
J. Biol. Chem., October 27, 2006; 281(43): 32353 - 32365.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
G. W. Buchko, C.-Y. Kim, T. C. Terwilliger, and M. A. Kennedy
Solution Structure of the Conserved Hypothetical Protein Rv2302 from Mycobacterium tuberculosis.
J. Bacteriol., August 1, 2006; 188(16): 5993 - 6001.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
R. A. Rieger, E. I. Zaika, W. Xie, F. Johnson, A. P. Grollman, C. R. Iden, and D. O. Zharkov
Proteomic Approach to Identification of Proteins Reactive for Abasic Sites in DNA
Mol. Cell. Proteomics, May 1, 2006; 5(5): 858 - 867.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A. Banerjee, W. L. Santos, and G. L. Verdine
Structure of a DNA glycosylase searching for lesions.
Science, February 24, 2006; 311(5764): 1153 - 1157.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. P. de Jesus, L. Serre, C. Zelwer, and B. Castaing
Structural insights into abasic site for Fpg specific binding and catalysis: comparative high-resolution crystallographic studies of Fpg bound to various models of abasic site analogues-containing DNA
Nucleic Acids Res., October 20, 2005; 33(18): 5936 - 5944.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
G. Golan, D. O. Zharkov, H. Feinberg, A. S. Fernandes, E. I. Zaika, J. H. Kycia, A. P. Grollman, and G. Shoham
Structure of the uncomplexed DNA repair enzyme endonuclease VIII indicates significant interdomain flexibility
Nucleic Acids Res., September 6, 2005; 33(15): 5006 - 5016.
[Abstract]